featured
ESMO 2018: Weekly Paclitaxel Plus Bevacizumab for Relapsed Ovarian Sex Cord Tumors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: